Table 5.

Detailed 6-factor decomposition results for GBD level 2 diseases

Disease	Pop. growth (%)	Pop. structure (%)	Treated (%)	Utilization (%)	Length of stay (%)	Cost per day (%)	Total (2013–2017, %)	Disease costs (2013, mCHF)
Cardiovascular diseases	5.7	2.6	2	0.6	0.2	8.5	19.7	450
Musculoskeletal disorders	5.6	1	$-$ 2.9	0.1	$-$ 10.7	18.3	11.4	373
Neoplasms	5.8	1.4	7.3	3	$-$ 11	13.2	19.8	362
Injury of one body part	5.6	1.5	$-$ 3.6	0.9	$-$ 2.8	11.8	13.4	258
Other non$-$communicable diseases	5.7	0.6	9.6	2	$-$ 10.8	10.7	17.8	233
Digestive diseases	5.4	1.2	$-$ 1.4	0.3	$-$ 11.5	11.4	5.3	221
Well care	5.4	$-$ 0.1	$-$  3.2	$-$0.4	$-$ 9.2	12.6	5	116
Maternal and neonatal disorders	5.8	0.3	13	1.7	$-$ 8.3	7.1	19.5	105
Other infectious diseases	5.5	1.9	$-$ 31.7	$-$ 0.6	9.4	21.9	6.4	90
Injury of multiple body parts	6.3	1.5	28.8	1.6	$-$ 12.5	16.1	41.8	88
Chronic respiratory diseases	5.5	0.9	6.9	2.1	$-$ 8.9	5.1	11.6	61
Neurological disorders	5.6	1.1	0	1.8	$-$ 6.7	11.4	13.2	58
Respiratory infections and tuberculosis	6	2.7	24.9	0.2	$-$ 12.9	6.9	27.8	52
Non$-$distinctive codes	5	1.9	$-$ 10.2	0.2	$-$ 19.1	10.9	$-$ 11.2	46
Skin and subcutaneous diseases	5.3	1.4	2.7	$-$ 0.9	$-$ 8.2	1.2	1.4	37
Sense organ diseases	5.3	1.7	$-$ 12.5	1.1	6.2	$-$ 2.1	$-$ 0.3	28
Mental disorders	5.8	2.1	0.6	2.2	$-$ 3.1	14.6	22.3	28
Diabetes and kidney diseases	5.7	1.6	$-$ 1.6	3.8	$-$ 6.3	16.2	19.4	24
Unintentional injuries	4.8	0.9	$-$ 15.3	0.6	$-$ 20	10.3	$-$ 18.6	12
Enteric infections	5.5	2	0.4	$-$ 0.9	$-$ 5.5	10.2	11.7	12
Substance use disorders	5.5	$-$ 0.2	12.5	2.5	$-$ 49.4	26.6	$-$ 2.5	9
Nutritional deficiencies	5.4	2.2	$-$ 6.6	$-$ 1.1	1.7	2.7	4.3	4
HIV/AIDS and sexually transmitted infections	4.9	$-$ 0.8	$-$ 11.9	$-$ 0.1	$-$ 14.3	16.7	$-$ 5.5	3
Neglected tropical diseases and malaria	5.9	$-$ 1.3	$-$ 12.8	5.8	15.3	13.6	26.4	1